Differential in vitro inhibition of thrombin generation by anticoagulant drugs in plasma from patients with cirrhosis.
<h4>Background</h4>Treatment and prevention of thrombotic complications is frequently required in patients with cirrhosis. However anticoagulant therapy is often withheld from these patients, because of the perceived bleeding diathesis. As a result of the limited clinical experience, the...
Enregistré dans:
Auteurs principaux: | Wilma Potze, Freeha Arshad, Jelle Adelmeijer, Hans Blokzijl, Arie P van den Berg, Joost C M Meijers, Robert J Porte, Ton Lisman |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2014
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/ab5c946e84b14f6f9c4891e1f2c3c61f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Anticoagulation in Patients with Liver Cirrhosis (Literature Review)
par: E. S. Eniseeva
Publié: (2019) -
The in vitro addition of idarucizumab to plasma samples from patients increases thrombin generation
par: Mojca Božič Mijovski, et autres
Publié: (2021) -
Role of a thrombin generation assay in the prediction of infection severity
par: Boaz Elad, et autres
Publié: (2021) -
Aggravation of fibrin deposition and microthrombus formation within the graft during kidney transplantation
par: Tamar A. J. van den Berg, et autres
Publié: (2021) -
Prognostic value of thrombin generation parameters in hospitalized COVID-19 patients
par: María Eugenia de la Morena-Barrio, et autres
Publié: (2021)